To Examine Whether or Not the Primary Causes of OA or RA Might be Bone Alterations

Sponsor
Shinshu University (Other)
Overall Status
Recruiting
CT.gov ID
NCT02327650
Collaborator
(none)
200
2
109
100
0.9

Study Details

Study Description

Brief Summary

Generally, osteoarthris (OA) is considered as primarily cartilage disease. However, as we and others have previously reported, a portion of OA might be caused primarily by bone alterations. In this study, we prospectively and retrospectively show that the bone altertations may affect OA primarily in all of the joints.

In addition, rheumatoid arthritis (RA) is a joint disease when immune system attacks synovium. Joint destruction occurrs continuously if suitable treatment is not performed. The etiology of RA is still largely unknown. As with OA, RA can be primarily damaged in bone, instead of cartilage. Here we prospectively and retrospectively show that the bone altertations may affect RA primarily in all of the joints.

Condition or Disease Intervention/Treatment Phase
  • Procedure: The examinations for bones in joints of OA and RA patients

Study Design

Study Type:
Observational
Anticipated Enrollment :
200 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
The Examinations Whether or Not the Primary Causes of Osteoarthritis or Rheumatoid Arthritis in Joints Might be Bone Alterations
Actual Study Start Date :
Nov 1, 2015
Anticipated Primary Completion Date :
Apr 1, 2022
Anticipated Study Completion Date :
Dec 1, 2024

Arms and Interventions

Arm Intervention/Treatment
RA and OA

Every 2 or 3 months, plain radiograph, blood and urinary tests, and MRI are performed in the painful joints of RA.

Procedure: The examinations for bones in joints of OA and RA patients

Outcome Measures

Primary Outcome Measures

  1. The bone signal changes detected by MRI in OA and/or RA patients [1 year]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • RA and/or OA
Exclusion Criteria:
  • N/A

Contacts and Locations

Locations

Site City State Country Postal Code
1 Yukio Nakamura Matsumoto Nagano Japan 3908621
2 Yukio Nakamura Matsumoto Japan

Sponsors and Collaborators

  • Shinshu University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Yukio Nakamura, Assistant Professor, Shinshu University
ClinicalTrials.gov Identifier:
NCT02327650
Other Study ID Numbers:
  • OA RA Bone Study
First Posted:
Dec 30, 2014
Last Update Posted:
Sep 21, 2021
Last Verified:
Sep 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 21, 2021